Childhood allergy care is evolving rapidly, bringing new approaches to diagnosis and treatment. If your child has a food allergy, eczema, allergic rhinitis, asthma, or a history of anaphylaxis, you may come across new tests and therapies that were not commonly discussed a few years ago. These developments are helping specialists understand allergies in a more detailed and personalised way.
One of the biggest advances is the move towards more precise diagnosis. Instead of relying only on a simple positive or negative allergy test, doctors can now consider factors such as specific allergen proteins, symptom patterns, biomarkers, and supervised food challenges. This helps create a clearer picture of your child’s allergy and reduces unnecessary restrictions.
Treatment options are also continuing to develop, particularly in areas such as food allergy immunotherapy, biologic medicines, and improved emergency management of anaphylaxis. However, new treatments are not suitable for every child, and availability can vary depending on individual circumstances. With specialist guidance, you can understand which options may be appropriate for your child’s needs.
Moving Towards Personalised Allergy Care
Traditional allergy management often focused on identifying a suspected allergen and recommending complete avoidance. Avoidance remains essential for confirmed food allergies, but modern care now looks more closely at your child’s individual risk, reaction patterns, and quality of life. This helps create a management plan based on your child’s specific needs rather than a standard approach.
Two children with the same allergy diagnosis can have very different experiences. They may have different reaction thresholds, co-factors, associated conditions and treatment needs. These differences are among the reasons why allergy management should be individualised. Understanding these differences helps your specialist provide more accurate advice for your child.
This personalised approach is also becoming important in conditions such as eczema, asthma, and allergic rhinitis. Doctors can combine your child’s medical history, allergy tests, inflammatory markers, and treatment response to decide the most appropriate level of care. This allows you to have a clearer understanding of your child’s condition and the best way to manage it.
| Advance | Current clinical position | What it may mean for your child |
| Clinical history plus targeted testing | Established and central to diagnosis | Helps avoid irrelevant testing and unnecessary restrictions |
| Skin prick and specific IgE testing | Established | Supports diagnosis when interpreted with reaction history |
| Component-resolved diagnostics | Available in selected situations | Can provide more detailed information about sensitisation patterns and cross-reactivity |
| Oral food challenge | Established specialist assessment | Can clarify whether a child is allergic or has developed tolerance |
| Basophil activation testing | Specialist/emerging | May help in selected complex cases where standard assessment is unclear |
| Oral immunotherapy | Specialist treatment for selected patients; access varies | May increase the amount of allergen tolerated but does not simply cure allergy |
| Food-allergy biologics | Important clinical research area; licensing and availability vary by country and indication | May offer protection against several allergens in selected patients |
| Epicutaneous immunotherapy | Emerging | Skin-patch approaches remain an active research area |
| AI-supported assessment | Research stage; not routine allergy assessment | May eventually help combine complex clinical and laboratory data |
| Nasal adrenaline | Now approved in the UK for specified age and weight groups | Provides a needle-free emergency adrenaline option for eligible patients |
Why Accurate Diagnosis Matters More Than Ever
An allergy diagnosis can influence many areas of your child’s daily life. It may affect what foods they eat, school arrangements, medicines kept available, and how confidently your family manages travel or social activities. This is why getting the diagnosis right is so important.
Overdiagnosis can be just as challenging as missing a genuine allergy. A careful assessment considers your child’s medical history and focuses testing on foods or triggers that are truly suspected of causing symptoms. This helps avoid unnecessary restrictions based only on test results.
A more accurate diagnosis allows you to manage genuine risks without imposing unnecessary restrictions on your child’s diet and daily life. The aim is not to identify as many possible allergens as possible but to understand which ones genuinely affect your child. This creates a safer and more practical approach to allergy care.
The Clinical History Is Still the Starting Point
Even with advances in allergy testing, your child’s allergy history remains one of the most important parts of diagnosis. Your specialist will want to understand what happened, how quickly symptoms appeared, what your child was exposed to, and whether a similar reaction has occurred before. These details help build a clearer picture of the allergy.
A test result on its own may not always provide the full answer. Your child may show sensitivity to an allergen during testing but not develop symptoms when exposed in everyday life. This is why test results need to be interpreted alongside your child’s symptoms and medical history.
The information you provide can make the assessment more accurate. Details such as photos of reactions, food labels, timing of symptoms, treatments used, and previous exposures can all be helpful. Keeping clear records allows your specialist to make better-informed decisions about your child’s care.
Advances in Skin Prick Testing
Skin prick testing remains an important tool for assessing immediate allergic sensitisation in children. Small amounts of selected allergens are placed on the skin, and the reaction is measured after a short time. The results are interpreted alongside your child’s symptoms and medical history.
Recent advances focus more on improving how the test is selected and interpreted rather than replacing the test itself. Testing for too many allergens without a clear reason can lead to confusing results and unnecessary restrictions.
Researchers are also exploring ways to make results more consistent through improved measurement methods and digital tools. However, these technologies are still developing, and specialist interpretation remains important for your child’s diagnosis.
More Precise Specific IgE Blood Testing
Specific IgE blood tests help measure your child’s immune response to particular allergens. They are often used alongside medical history and can provide additional information when skin testing is not suitable or when further assessment is needed.
Modern interpretation looks beyond a simple positive or negative result. Specialists may consider the level, changes over time, the specific allergen, previous reactions, and your child’s overall allergy profile.
These tests can be particularly useful during follow-up assessments. Changing results may help guide decisions about continued avoidance, further testing, or whether a supervised oral food challenge may be appropriate.
Component-Resolved Diagnostics
Component-resolved diagnostics, also known as molecular allergy testing, is an important development in allergy assessment. Instead of testing only a whole food extract, this approach looks at your child’s IgE response to individual allergenic proteins within that food.
This type of testing can help your specialist understand different sensitisation patterns more clearly. For you as a parent, this may provide a better explanation of why your child reacts to certain foods while tolerating others.
Component testing does not replace your child’s allergy history or tell you exactly how severe a future reaction will be. However, it can add valuable information when your specialist is deciding on diagnosis, food avoidance, or whether further assessment may be suitable.
Why Molecular Allergy Testing Can Be Helpful
Whole-allergen tests can sometimes show positive results because proteins in different allergens may look similar to the immune system. This can make interpretation more difficult, especially if your child also has pollen sensitisation or reactions to certain plant foods.
Molecular testing helps specialists look at specific allergenic proteins and understand whether the pattern suggests a genuine food allergy or cross-reactivity. For you, this may provide a clearer explanation of your child’s results and help guide decisions about management.
However, molecular testing is not needed for every child. Your specialist will consider whether the additional information is likely to change your child’s care plan. Using the right test at the right time can help avoid confusion and unnecessary restrictions.
The Growing Role of Basophil Activation Testing
Basophil activation testing (BAT) is an emerging allergy test that measures how certain immune cells respond to allergens in a laboratory setting. BAT measures how basophils respond after laboratory exposure to a suspected allergen. In selected specialist cases, it may provide additional diagnostic information when the clinical history and conventional allergy tests do not give a clear answer.
Research is continuing into how BAT can support the diagnosis of complex food allergies, including conditions where standard testing may not provide clear answers. For you, this may represent a future step towards more accurate and personalised allergy assessment.
BAT is not currently a routine test for every child and is mainly used in specialised settings. However, further research and greater standardisation may help clarify how BAT can be integrated into specialist diagnostic pathways.
| Diagnostic tool | Main role | Important limitation |
| Clinical history | Establishes whether the reaction pattern is consistent with allergy | Depends on accurate recall and exposure information |
| Skin prick test | Detects IgE sensitisation | Positive result does not prove clinical allergy |
| Specific IgE | Measures allergen-specific IgE in blood | Level alone does not predict every future reaction |
| Component diagnostics | Examines IgE to individual allergen proteins | Not necessary for every child |
| BAT | Measures basophil activation after in-vitro allergen exposure | Specialist availability is limited |
| Oral food challenge | Directly assesses clinical reactivity or tolerance | Requires careful selection and supervised clinical facilities |
Evidence Note:
BAT measures the response of basophils after laboratory exposure to a suspected allergen. Its potential value is greatest in selected difficult diagnostic situations, particularly when conventional clinical history, skin testing and specific IgE results do not provide a clear answer. However, BAT remains a specialist test rather than a routine test for every child, and practical limitations such as availability and laboratory expertise remain important.
Oral Food Challenges Remain Highly Important
Even with advances in allergy testing, a supervised oral food challenge remains an important part of food allergy diagnosis. It can help determine whether your child is still allergic or has developed tolerance to a particular food.
During a food challenge, carefully measured amounts of the food are given under medical supervision. Your child is monitored closely, and the clinical team is prepared to manage a reaction if one occurs.
New diagnostic tools may help specialists decide when a food challenge is needed and which children are most suitable. This can help you avoid unnecessary food restrictions while ensuring your child’s safety remains the priority.
Better Distinction Between Sensitisation and True Allergy
Modern allergy care increasingly recognises that sensitisation does not always mean your child has a true food allergy. A positive skin or blood test only shows an immune response and does not always mean symptoms will occur after eating the food.
Making this distinction is important because an incorrect diagnosis can lead to unnecessary food avoidance for years. It can also affect your child’s confidence during school activities, travel, and family meals.
A more accurate approach combines test results with your child’s reaction history and, when needed, a supervised food challenge. This helps specialists create a plan that protects your child while supporting a better quality of life.
Key Fact: A Positive Test Is Not the Whole Diagnosis
Skin prick tests and specific IgE blood tests identify allergic sensitisation, but the result must be interpreted alongside your child’s clinical history. A positive result does not automatically prove that eating the food will cause symptoms. This is why specialists consider what actually happened during exposure, the timing of symptoms, the amount eaten and whether an oral food challenge is appropriate.
Better Recognition of Non-IgE-Mediated Allergy
Not all food allergies cause immediate symptoms such as hives, swelling, or breathing difficulties. Some children have non-IgE-mediated allergies, which can cause delayed digestive or skin symptoms that may be harder to link to a specific food.
Diagnosis often relies more on your child’s symptom history, carefully planned elimination, and supervised food reintroduction. Standard allergy tests may not always identify these types of reactions.
Improved awareness of non-IgE-mediated allergy is helping specialists provide clearer guidance for families. This is especially important in babies and young children, where feeding difficulties, reflux-like symptoms, eczema, and bowel problems can sometimes overlap.
More Careful Use of Allergy Tests
Having access to advanced allergy tests does not mean that every child needs every available test. Modern allergy care focuses on choosing investigations based on your child’s symptoms, medical history, and specific concerns.
Broad allergy testing can sometimes identify sensitisation that is not linked to real-life reactions. This may lead to unnecessary food avoidance and restrictions that affect your child’s diet and daily life.
A good allergy assessment starts with a clear question before testing is recommended. The results should help you and your specialist understand the diagnosis, guide food reintroduction, monitor changes, or support treatment decisions.
UK Guidance Note:
NICE guidance for children and young people with suspected food allergy places the allergy-focused clinical history at the centre of assessment. It covers targeted diagnosis of IgE-mediated and non-IgE-mediated food allergy, appropriate referral and the careful use of diagnostic tools. For parents, the practical message is that more testing is not automatically better testing. The right investigation should be chosen to answer a clear clinical question raised by your child’s symptoms and history.
Oral Immunotherapy
Oral immunotherapy (OIT) is one of the most discussed developments in food allergy treatment. It involves giving carefully measured and gradually increased amounts of an allergen with the aim of increasing the amount your child can consume before reacting. This is generally described as desensitisation and does not necessarily mean that the allergy has permanently resolved.
OIT is not generally described as a cure. Its main aim is to increase the reaction threshold and reduce risk from accidental exposure, although outcomes and treatment requirements vary. Children usually still need specialist supervision, ongoing treatment, and an emergency plan because reactions can still happen.
International guidance supports oral immunotherapy for selected children and adolescents with IgE-mediated peanut allergy, but UK availability has changed following the withdrawal of Palforzia for new patients. Families should seek current specialist advice before considering any form of food allergy immunotherapy.
How Emerging Food-Allergy Treatments Differ
| Approach | Basic principle | Main limitation |
| Oral immunotherapy | Repeated controlled ingestion of allergen | Reactions can occur and ongoing treatment may be needed |
| Sublingual immunotherapy | Small allergen amounts delivered under the tongue | Food-allergy use remains limited and developing |
| Epicutaneous immunotherapy | Allergen delivered through the skin | Still emerging and not routinely available everywhere |
| Anti-IgE biologic therapy | Reduces IgE-driven allergic reactivity | Access, licensing and eligibility vary by country and indication |
Changes in the UK Peanut Immunotherapy Landscape
Peanut immunotherapy has become an important development in food allergy care. Palforzia was previously the first licensed oral immunotherapy treatment for peanut allergy and used controlled amounts of peanut protein to help children build tolerance to accidental exposure.
However, the availability of this treatment has changed after the manufacturer decided to stop production worldwide. If your child was being considered for this option, it is important to understand that the decision was not related to safety, quality, or effectiveness concerns.
This situation shows why you need current specialist advice when exploring food immunotherapy. Treatment access and suitable alternatives can change over time, so your child’s allergy team can help you understand which options may be appropriate.
Immunotherapy Is Not a Home Treatment
The idea of giving small amounts of an allergenic food may seem straightforward, but immunotherapy is a specialist treatment that should not be started at home. If your child is undergoing immunotherapy, reactions can still occur during dose increases, maintenance, or times of illness.
The dose amount, treatment schedule, medical supervision, and emergency planning all play an important role. Your specialist will assess whether this approach is suitable for your child, as one treatment plan may not be appropriate for every child.
It is also important for you to understand the difference between supervised immunotherapy and normal food reintroduction. If your child has a suspected severe allergy, you should not intentionally expose them at home to see what happens. A carefully planned medical approach helps keep your child safe.
Sublingual Immunotherapy Research
Sublingual immunotherapy involves placing small amounts of an allergen under your child’s tongue in a controlled way. Researchers are exploring whether this method can safely increase tolerance using smaller doses compared with traditional oral immunotherapy.
- Specialist Supervision: Current guidance recommends this treatment only in selected cases under the care of a specialist.
- Limited Availability: Sublingual immunotherapy is not widely available and may not be suitable for every child.
- Ongoing Research: Studies continue to assess its long-term benefits and limitations, including effectiveness and safety.
- Individual Suitability: Your specialist can advise whether this approach is appropriate based on your child’s allergy history and specific needs.
Overall, sublingual immunotherapy is a developing treatment that may offer a gentler alternative for some children. Careful assessment and specialist supervision are essential to ensure safety and effectiveness.
Epicutaneous Immunotherapy
Epicutaneous immunotherapy delivers small amounts of an allergen through the skin, usually using a patch-based system. The aim is to help your child’s immune system become less reactive without requiring them to swallow the allergen.
This approach may be appealing if you are concerned about oral dosing, especially for younger children. However, its effectiveness, suitability, and availability are still being studied, and it is not yet widely available as a routine treatment option.
Research into skin-based immunotherapy shows that allergy treatment may offer more personalised choices in the future. Your specialist can help you understand whether emerging options may be suitable for your child’s age, allergy pattern, and overall situation.
Clinical Insight: Promising Does Not Mean Routinely Available
Some allergy treatments discussed in research, including food-allergy patches and newer immunotherapy delivery methods, may produce encouraging trial results before becoming licensed or routinely accessible. Clinical trial success, regulatory approval, commissioning and practical availability are separate stages. Your child’s allergy specialist can explain whether an option is established, available through a specialist service, or still investigational.
Biologic Medicines and Food Allergy
Biologic medicines are an important area of development in allergy care. These treatments work by targeting specific parts of the immune system rather than affecting the whole immune response. This approach may help create more targeted treatment options for some children.
Omalizumab has gained attention in food allergy research because it targets IgE-related pathways involved in allergic reactions. If your child has IgE-mediated food allergy, your specialist may consider whether this type of treatment could be relevant, depending on individual circumstances.
However, research developments do not always mean a treatment is immediately available everywhere. You should check with your child’s allergy team about licensing, eligibility, and access within UK services. They can help you understand which options are currently suitable for your child’s care.
Why Omalizumab Research Matters
Research into omalizumab and food allergy has explored whether this medicine can increase the amount of allergen needed to trigger a reaction. For some children, this could potentially reduce the risk linked with accidental exposure when used under specialist guidance.
Researchers are also investigating whether biologic medicines may support other treatments, such as immunotherapy, by improving safety or effectiveness. If your child is being considered for advanced allergy treatments, your specialist can explain how these approaches may fit into their care.
It is important to remember that these treatments do not mean your child can stop avoiding known allergens or carrying emergency medication when advised. You should continue following your child’s allergy plan, as treatment decisions depend on evidence, eligibility, specialist assessment, and availability.
Research Insight:
Omalizumab has produced important results in food-allergy research. In evidence supporting its US food-allergy approval, 68% of treated participants were able to consume at least 600 mg of peanut protein without moderate-to-severe allergic symptoms, compared with 6% receiving placebo. Results were also favourable for several other foods studied. However, treatment availability and licensing vary between countries, and UK families should not assume that a research result or overseas approval means the treatment is routinely available for childhood food allergy in the UK.
Treatment for Multiple Food Allergies
Children with multiple food allergies often face more complex challenges. Avoiding several foods can affect daily routines, nutrition, social activities, and family confidence. If your child has several allergies, careful planning is important to keep their diet safe and balanced.
Biologic treatments are an area of growing interest because one immune-targeted medicine may potentially help with responses to multiple foods. This is different from allergen-specific immunotherapy, which usually focuses on increasing tolerance to one particular food.
Research in this area is continuing, and treatment options are not the same for every child. Your specialist can help you understand whether advanced treatments may be suitable, while accurate diagnosis remains essential to avoid unnecessary food restrictions.
Better Allergy Risk Assessment
Modern allergy care is moving beyond simple labels such as “allergic” or “not allergic”. Specialists now look at factors such as your child’s reaction history, test results, asthma control, possible triggers, and the amount of allergen linked with previous symptoms.
Better assessment does not mean doctors can predict every future reaction with complete accuracy. If your child has an allergy, reactions can still vary, and factors such as illness, exercise, or other conditions may influence symptoms.
The main benefit is a more personalised management plan. Your specialist can help you understand whether your child needs closer monitoring, continued precautions, or reassessment because their allergy may be changing over time.
Advances in Predicting Allergy Resolution
For allergies that children often outgrow, repeat assessments can help identify whether tolerance may be developing. Your specialist may consider changes in specific IgE levels, skin test results, component testing, and any accidental exposures when reviewing your child’s progress.
No single test can confirm that an allergy has completely disappeared. Instead, doctors combine different pieces of information before deciding whether a supervised food challenge or structured reintroduction may be suitable.
Better prediction can help prevent unnecessary long-term food restrictions. If your child’s allergy appears to be changing, you can work with the allergy team to consider safer ways of expanding their diet at the right time.
More Individualised Food Challenges
Food challenges are becoming more personalised, with decisions based on your child’s allergy history and individual risk. Specialists may consider the food form, starting dose, dose increases, and the clinical setting before planning the challenge.
Some children with milk or egg allergy may tolerate extensively heated forms before less-heated versions. Understanding these patterns can help your specialist decide the safest way to assess tolerance and guide reintroduction.
The goal is not to perform food challenges unnecessarily but to answer an important medical question safely. A well-planned challenge can give you clearer advice about what your child can eat and how to manage their allergy moving forward.
Better Management of Eczema and Allergy Together
Research increasingly highlights the connection between early eczema, skin barrier problems, and food allergy risk. If your child has severe eczema in early life, careful assessment and appropriate feeding advice may be important parts of their care.
However, eczema does not always mean that food is causing the flare-ups. You should avoid removing foods from your child’s diet without a clear reason, as unnecessary restrictions can affect nutrition and increase family stress.
The focus is now on a more joined-up approach to allergy care. Your specialist can consider skin symptoms, feeding history, reactions, growth, and allergy risk together to create a more complete management plan.
Prevention Through Early Allergen Introduction
One of the biggest changes in allergy prevention has been the move away from routinely delaying allergenic foods. Current approaches support introducing suitable allergenic foods at the right stage for most babies rather than avoiding them without a medical reason.
If your baby has severe eczema or an existing food allergy, you may need individual advice from a healthcare professional. The timing and approach should be based on your baby’s health, risk factors, and feeding history.
This change reflects a wider shift in childhood allergy care, where prevention is now considered alongside diagnosis and treatment. With the right guidance, you can introduce foods safely while following an approach that supports your baby’s health and development.
Artificial Intelligence in Allergy Research
Artificial intelligence (AI) is becoming an area of interest in allergy research. It may help specialists combine information such as your child’s medical history, allergy tests, biomarkers, and other data to improve diagnostic accuracy.
Early research suggests that machine-learning tools may support better prediction of food allergy patterns. However, these systems are still developing and are designed to support specialist decision-making rather than replace clinical assessment.
AI has potential, but it is not yet a routine part of everyday allergy care. You should continue relying on your child’s allergy specialist, who can consider the full picture and provide advice based on your child’s individual needs.
Digital Tools and Allergy Management
Digital tools are becoming more useful for supporting everyday allergy management. They can help you track medication expiry dates, store allergy action plans, communicate with schools, and record important symptoms or reactions.
The main benefit of these tools is better organisation rather than replacing medical diagnosis. Keeping digital records can help you and your healthcare team identify patterns, update emergency information, and discuss your child’s progress more clearly.
Technology should make allergy care simpler, not create extra stress. The most helpful tools are those that support your routine, improve planning, and help you feel more prepared without increasing unnecessary worry.
Advances in Anaphylaxis Emergency Treatment
Adrenaline auto-injectors have long been the standard emergency treatment for children at risk of anaphylaxis. New developments in adrenaline delivery, including needle-free options, are creating more choices for families and healthcare professionals.
Recent approvals in the UK have introduced adrenaline nasal spray options for eligible patients. However, the right emergency treatment depends on factors such as your child’s age, weight, medical advice, availability, and individual allergy action plan.
You should not change your child’s emergency medication without speaking to their allergy team. Your specialist can help you understand whether a different device is suitable and ensure that your child’s emergency plan remains safe and up to date.
Why Needle-Free Adrenaline May Matter
Fear of needles can sometimes make children, teenagers, parents, or carers hesitate during an emergency. A needle-free adrenaline option may provide an alternative that feels more acceptable for some families.
However, a new device does not replace the need for proper emergency training. You still need to recognise the signs of anaphylaxis, understand how your child’s prescribed device works, and know when to seek urgent medical help.
Your child’s allergy action plan should remain the main guide until the prescribing team recommends any changes. If you are considering a different device, discuss it during a specialist review rather than making changes independently.
Better Emergency Action Planning
Modern allergy care places greater importance on having a clear written emergency action plan. A well-prepared plan helps you, family members, schools, nurseries, and carers recognise symptoms and respond quickly if your child has a serious allergic reaction.
The plan should match your child’s prescribed treatment and emergency medication. You should review it regularly, especially if your child’s weight, medication, device, school arrangements, or allergy status changes.
Although an action plan is not a new technology, it remains one of the most valuable parts of allergy management. New treatments and devices work best when you and those caring for your child understand exactly how and when to use them.
Greater Attention to Quality of Life
Allergy research is increasingly recognising the emotional and social impact of living with allergies. If your child has food restrictions, it can affect school meals, parties, eating out, travel, friendships, and everyday family routines.
Treatment success is not measured only by test results or reaction thresholds. Your child’s confidence, ability to take part in activities, and reduced fear around accidental exposure are also important parts of good allergy care.
This is particularly important when considering immunotherapy or advanced treatments. You should understand not only the possible benefits but also the time, monitoring, commitment, and lifestyle changes involved before making a decision.
The Growing Role of Shared Decision-Making
There may be more than one suitable way to manage your child’s allergy. Some families may choose specialist treatments to reduce accidental exposure risks, while others may prefer careful avoidance alongside strong emergency planning.
Shared decision-making allows you and your allergy team to discuss benefits, risks, uncertainties, and practical considerations. Your child’s age, daily routine, emotional wellbeing, other health conditions, and your family’s preferences all play an important role.
As new treatments become available, these conversations become even more important. Having more options means you need clear information so you can make confident decisions together with your child’s clinical team.
Why Asthma Control Matters in Food Allergy Care
Asthma and food allergy can occur together, making respiratory health an important part of your child’s allergy assessment. If your child has poorly controlled asthma, their allergy management plan may need additional review and support.
Your specialist may ask about symptoms such as night-time coughing, wheezing, exercise difficulties, reliever inhaler use, and recent asthma attacks. This helps ensure that both asthma and food allergy are being managed together rather than separately.
Good asthma control is especially important before certain allergy assessments or treatments. Your child’s overall health needs to be stable so that planned procedures can be carried out as safely as possible.
Advances in Allergy Prevention Research
Researchers are continuing to explore why allergies develop and how they may be prevented. Current areas of interest include your child’s skin barrier, early diet, genetics, environmental factors, and how the immune system develops in early life.
Allergy development is complex, and there is unlikely to be one prevention method that works for every child. A combination of inherited factors and environmental influences can affect how allergic conditions develop.
You should be cautious about products that claim to prevent allergies through unproven supplements, home testing kits, or unnecessary restrictive diets. Evidence-based prevention advice from healthcare professionals can help you make safer decisions for your child.
Microbiome Research
The microbiome refers to the communities of microorganisms that live in and on the body. Researchers are studying whether differences in the gut, skin, and airway microbiome may influence conditions such as eczema, food allergy, asthma, and allergic rhinitis.
This is an exciting area of research, but it has not yet produced a simple treatment that you can use to prevent or reverse childhood allergies. A specific probiotic product should not be assumed to treat an established food allergy without strong evidence.
Future studies may help specialists understand how microbial patterns affect immune tolerance. For now, microbiome research remains an evolving field rather than a routine treatment option for childhood allergy.
New Approaches to Pollen and Environmental Allergy
Allergen immunotherapy is already used for selected environmental allergies, and research continues into improving treatment methods, schedules, and patient selection. The aim is to help your child’s immune system respond differently to a specific allergen over time.
Immunotherapy may be given through injections or under-the-tongue treatments depending on the allergen, age, and clinical situation. However, it is not needed for every child with hay fever or environmental allergy.
If your child’s symptoms remain troublesome despite standard treatments, you may benefit from specialist advice. Your allergy team can consider factors such as the confirmed trigger, symptom severity, asthma control, and suitable treatment options.
Better Coordination Between Allergy Conditions
Children may experience several allergic conditions together, such as eczema, food allergy, asthma, and allergic rhinitis. Managing each condition separately can sometimes make care feel complicated and difficult to coordinate.
Modern allergy care focuses on looking at your child’s overall allergic profile. Specialists may consider skin symptoms, breathing, nasal problems, food reactions, growth, sleep, school impact, and family concerns together.
A joined-up approach can help identify whether one poorly controlled condition is affecting another. It also allows you to follow a clearer and more practical management plan rather than receiving separate pieces of advice.
What Parents Should Ask About New Treatments
When you hear about a new allergy treatment, it is helpful to understand what it is designed to achieve. Some treatments may increase tolerance to an allergen, while others may reduce symptoms or target specific parts of the immune system.
You should ask whether the treatment is suitable for your child’s age and condition, whether it is licensed in the UK, and whether it is routinely available. New research findings do not always mean that a treatment is immediately accessible in everyday clinical care.
It is also important to consider the practical side of treatment. Some options may require regular doses, frequent appointments, monitoring, and continued emergency planning. Understanding these commitments can help you decide whether a treatment is right for your child.
When Specialist Assessment Becomes Particularly Important
Specialist assessment can be especially valuable after anaphylaxis, repeated immediate food reactions, unexplained symptoms, difficult-to-control eczema, or suspected multiple food allergies. It can also help when you are unsure whether your child’s previous allergy has changed or resolved.
Your specialist may use a combination of clinical history, targeted skin testing, specific IgE testing, component diagnostics, or food challenges depending on what needs to be investigated. Advanced tests are chosen when they are likely to provide useful information for your child’s care.
The aim is not to use every available technology but to find the most reliable approach for your child. A careful assessment helps you understand the condition better and ensures that specialised testing or treatment is used when it can make a meaningful difference.
Accessing Modern Childhood Allergy Care
Modern allergy care is becoming more personalised, but new technology does not replace careful assessment by an experienced specialist. The best approach starts with understanding your child’s symptoms, reaction history, and the areas where your family needs support.
Depending on your child’s situation, you may be offered targeted testing, molecular diagnostics, supervised food challenges, immunotherapy discussions, updated emergency treatment options, or regular allergy reviews. These choices should be based on your child’s individual needs rather than only on a test result or online information.
With the right specialist guidance, you can better understand which advances are relevant for your child. Personalised care helps ensure that new developments are used safely and in a way that supports your child’s health and daily life.
Myth vs Fact:
| Myth | Fact |
| New allergy tests have replaced clinical history. | The clinical history remains central to deciding which tests are useful. |
| Component testing is better for every child. | It is most useful when the additional molecular information is likely to change diagnosis or management. |
| BAT is now a routine allergy test. | It remains a specialist or emerging investigation in selected situations. |
| A positive allergy test proves a child will react. | Sensitisation and clinical allergy are not the same thing. |
| OIT cures food allergy. | It aims to increase the amount tolerated and reduce accidental-exposure risk; ongoing precautions may still be needed. |
| Omalizumab is now routinely available for all UK children with food allergy. | Research is promising, but licensing and access differ between countries and clinical indications. |
| Palforzia is still available for new UK patients. | NICE states that no new people will start Palforzia in the UK following withdrawal of the guidance. |
| Nasal adrenaline means auto-injectors are obsolete. | Device choice depends on age, weight, prescribing advice and the child’s individual emergency plan. |
Key Takeaways:
- Childhood allergy diagnosis is becoming more precise, but clinical history remains the starting point.
- Skin prick and specific IgE tests must be interpreted alongside your child’s symptoms and exposure history.
- Component-resolved diagnostics can provide useful molecular information in selected cases.
- BAT is promising but remains a specialist test rather than routine testing for every child.
- Supervised oral food challenges remain important for confirming allergy or tolerance in appropriate cases.
- Oral immunotherapy may increase allergen tolerance in selected children but should not be described as a simple cure.
- Food-allergy SLIT and EPIT remain developing approaches and are not routine options for every child.
- Omalizumab has shown strong food-allergy trial results, but regulatory approval and availability differ between countries.
- NICE has withdrawn its Palforzia guidance for new UK starts; People already receiving Palforzia will be able to continue until March 2027, according to NICE, but no new people will start Palforzia in the UK.
- Availability may vary between services and prescribing pathways.
- The value of new technology lies in choosing the right test or treatment for the right child, not using every available advance.
FAQs:
1. What is the latest advancement in childhood allergy diagnosis?
Recent advances include component-resolved diagnostics, improved specific IgE interpretation, and emerging tests such as basophil activation testing. These tools provide more detailed information about how your child’s immune system responds to allergens. However, they do not replace a thorough clinical assessment. Your child’s symptoms and medical history remain central to making an accurate diagnosis.
2. Can a child have a positive allergy test without having a true allergy?
Yes, a positive allergy test does not always mean your child will develop symptoms when exposed to that allergen. The test may show sensitisation, which means the immune system recognises the allergen but does not necessarily react clinically. This is why specialists interpret test results alongside your child’s reaction history. In some cases, a supervised food challenge may be needed to confirm a diagnosis.
3. What is component-resolved diagnostics in allergy testing?
Component-resolved diagnostics is a form of molecular allergy testing that examines reactions to individual allergenic proteins. This can help specialists distinguish between a true food allergy and cross-reactivity caused by similar proteins in different allergens. The additional information may improve diagnostic accuracy in selected cases. However, it is not necessary for every child with suspected allergies.
4. Are oral food challenges still necessary with modern allergy tests?
Yes, oral food challenges remain one of the most important tools in allergy diagnosis. Even advanced blood tests and molecular diagnostics cannot always confirm whether a child will react when eating a food. During a challenge, carefully measured amounts of food are given under specialist supervision. This helps determine whether the allergy is still present or whether tolerance has developed.
5. What is oral immunotherapy for food allergies?
Oral immunotherapy (OIT) involves giving gradually increasing amounts of an allergen under specialist supervision. The aim is to increase the amount of food your child can tolerate before experiencing a reaction. It is designed to reduce the risk from accidental exposure rather than provide a guaranteed cure. Children undergoing OIT still require monitoring and an allergy management plan.
6. Is oral immunotherapy suitable for every child with a food allergy?
No, oral immunotherapy is not suitable for every child. Specialists consider factors such as age, allergy severity, asthma control, medical history, and family circumstances before recommending treatment. Some children may benefit significantly, while others may be better managed with avoidance strategies and emergency planning. A specialist assessment is essential before considering OIT.
7. What role do biologic medicines play in childhood allergy treatment?
Biologic medicines target specific parts of the immune system involved in allergic reactions. Omalizumab is one example that has shown promising results in food allergy research. These treatments may help reduce allergic responses and are being studied alongside immunotherapy approaches. Availability and eligibility vary, so specialist advice is important.
8. What is the difference between sensitisation and clinical allergy?
Sensitisation means your child’s immune system recognises an allergen and may produce a positive test result. Clinical allergy means exposure to that allergen actually causes symptoms such as hives, swelling, vomiting, or breathing difficulties. Not all sensitised children will experience allergic reactions. Understanding this difference helps prevent unnecessary food restrictions and anxiety.
9. Are there new treatments available for anaphylaxis emergencies?
Yes, alongside traditional adrenaline auto-injectors, needle-free adrenaline nasal sprays have recently become available for certain age groups in the UK. These devices provide an alternative method of delivering emergency adrenaline during anaphylaxis. However, they are not suitable for everyone and should only be used if prescribed by your child’s healthcare team. Families should continue following their existing emergency action plan unless advised otherwise.
10. When should a child be referred to a paediatric allergy specialist?
A specialist assessment may be helpful if your child has experienced anaphylaxis, repeated allergic reactions, suspected multiple food allergies, or difficult-to-control eczema linked to possible allergies. Referral may also be appropriate when there is uncertainty about a diagnosis or whether an allergy has resolved. Specialists can provide access to advanced testing and supervised food challenges when needed. Early expert assessment can help ensure accurate diagnosis and appropriate management.
Final Thoughts: The Future of Childhood Allergy Care Is Becoming More Personalised
The field of childhood allergy care is evolving rapidly, with advances in diagnostic testing, immunotherapy, biologic medicines, and emergency treatment helping clinicians make more informed and individualised decisions. While newer technologies and treatments are creating exciting opportunities, they work best when combined with a detailed clinical history, careful assessment, and a clear understanding of your child’s specific symptoms and risks. The goal is not simply to identify allergies but to provide accurate diagnoses, avoid unnecessary restrictions, and improve your child’s safety and quality of life.
As research continues to develop, more children may benefit from tailored treatment plans that take into account their allergy profile, medical history, lifestyle, and family circumstances. However, not every new test or treatment is suitable for every child, which is why specialist guidance remains so important.
If you are seeking advice from a specialist children’s allergy clinic in London with experience in modern allergy diagnosis and management, London Paediatric Clinic can provide expert assessment, discuss the latest evidence-based options, and help create a personalised plan for your child’s needs.
References:
- National Institute for Health and Care Excellence (NICE) (2011) Food allergy in under 19s: assessment and diagnosis. NICE clinical guideline CG116. Available at: https://www.nice.org.uk/guidance/cg116
- Santos, A.F. et al. (2025) EAACI guidelines on the management of IgE-mediated food allergy, Allergy, 80(1), pp.14–36. Available at: https://pubmed.ncbi.nlm.nih.gov/39473345/
- National Institute for Health and Care Excellence (NICE) (2022, withdrawn 2026) Palforzia for treating peanut allergy in children and young people. Technology appraisal guidance TA769. Available at: https://www.nice.org.uk/guidance/ta769
- British Society for Allergy and Clinical Immunology (BSACI) (2026) Stallergenes Greer decides to discontinue Palforzia. Available at: https://www.bsaci.org/stallergenes-greer-decides-to-discontinue-palforzia/
- British Society for Allergy and Clinical Immunology (BSACI) (no date) Early introduction of food allergens. Available at: https://www.bsaci.org/resources/allergy-management/food-allergy/allergy-prevention/early-introducti…
- Medicines and Healthcare products Regulatory Agency (MHRA) (2025) MHRA approves adrenaline nasal spray the first needle-free emergency treatment for anaphylaxis in the UK. Available at: https://www.gov.uk/government/news/mhra-approves-adrenaline-nasal-spray-the-first-needle-free-emerg…
- Medicines and Healthcare products Regulatory Agency (MHRA) (2026) Lower dose needle-free allergy treatment approved for younger children. Available at: https://www.gov.uk/government/news/lower-dose-needle-free-allergy-treatment-approved-for-younger-ch…
- Resuscitation Council UK (2021) Emergency treatment of anaphylaxis: Guidelines for healthcare providers. Available at: https://www.resus.org.uk/library/additional-guidance/guidance-anaphylaxis
- Wood, R.A. et al. (2024) Omalizumab for the treatment of multiple food allergies, New England Journal of Medicine, 390(10), pp.889–899. Available at: https://pubmed.ncbi.nlm.nih.gov/38407394/
- Foong, R.X. et al. (2021) Improving diagnostic accuracy in food allergy, Journal of Allergy and Clinical Immunology: In Practice, 9(1), pp.71–80. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7794657/
- Dodd, A. et al. (2021) Evidence update for the treatment of anaphylaxis, Resuscitation, 163, pp.86–96. Available at: https://www.sciencedirect.com/science/article/pii/S0300957221001507